Based on the agreement between Ministry of Health and Roche company, besides patients with early stage of breast cancer (I, II, III), patients with IV-category breast cancer will be also able to use 80% discount program for buying corresponding medications.
“The discount offer from the manufacturer has enabled to involve more patients in the program by the same budget and offer 80% discount scheme to patients with fourth-category breast cancer”, Minister of Health of Georgia David Sergeenko said.
Thanks to close cooperation between the public and private sectors, all categories of patients with breast cancer will be thoroughly involved in the program. More than 1500 breast cancer cases are reported annually in Georgia. Price of the corresponding medication Herceptin, which considerably grows the disease remission and lifespan, exceeds 72 000 GEL annually per patient.
The breast cancer program started in February 2016 with the aim to expand affordability of corresponding medications.